These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 29145934)
21. Antimicrobial stewardship in children: more shadows than lights? Tersigni C; Venturini E; Montagnani C; Chiappini E; de Martino M; Galli L Expert Rev Anti Infect Ther; 2019 Nov; 17(11):871-876. PubMed ID: 31661998 [No Abstract] [Full Text] [Related]
22. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E; Value Health; 2013; 16(2):231-50. PubMed ID: 23538175 [TBL] [Abstract][Full Text] [Related]
23. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation. Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127 [TBL] [Abstract][Full Text] [Related]
24. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems. Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668 [TBL] [Abstract][Full Text] [Related]
25. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect? Allen D; Rixson L Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815 [TBL] [Abstract][Full Text] [Related]
26. Economic evaluations of follow-up strategies for cancer survivors: a systematic review and quality appraisal of the literature. Meregaglia M; Cairns J Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):913-29. PubMed ID: 26449255 [TBL] [Abstract][Full Text] [Related]
27. Conducting systematic reviews of economic evaluations. Gomersall JS; Jadotte YT; Xue Y; Lockwood S; Riddle D; Preda A Int J Evid Based Healthc; 2015 Sep; 13(3):170-8. PubMed ID: 26288063 [TBL] [Abstract][Full Text] [Related]
28. The need for cost-effectiveness analyses of antimicrobial stewardship programmes: A structured review. Coulter S; Merollini K; Roberts JA; Graves N; Halton K Int J Antimicrob Agents; 2015 Aug; 46(2):140-9. PubMed ID: 26058776 [TBL] [Abstract][Full Text] [Related]
29. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis. Frampton GK; Jones J; Rose M; Payne L Health Technol Assess; 2016 Nov; 20(87):1-160. PubMed ID: 27918253 [TBL] [Abstract][Full Text] [Related]
30. Health economic analyses of psoriasis management: a systematic literature search. Gutknecht M; Krensel M; Augustin M Arch Dermatol Res; 2016 Nov; 308(9):601-616. PubMed ID: 27435415 [TBL] [Abstract][Full Text] [Related]
31. Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals. Chhatwal J; He T; Lopez-Olivo MA Pharmacoeconomics; 2016 Jun; 34(6):551-67. PubMed ID: 26748919 [TBL] [Abstract][Full Text] [Related]
32. The Pharmacoeconomic Aspects of Antibiotic Stewardship Programs. Cunha CB Med Clin North Am; 2018 Sep; 102(5):937-946. PubMed ID: 30126582 [TBL] [Abstract][Full Text] [Related]
33. Antimicrobial Stewardship Programs: Principles and Practice. Cunha CB Med Clin North Am; 2018 Sep; 102(5):797-803. PubMed ID: 30126571 [TBL] [Abstract][Full Text] [Related]
34. Systematic review, critical appraisal, and analysis of the quality of economic evaluations in stroke imaging. Burton KR; Perlis N; Aviv RI; Moody AR; Kapral MK; Krahn MD; Laupacis A Stroke; 2014 Mar; 45(3):807-14. PubMed ID: 24519409 [TBL] [Abstract][Full Text] [Related]
35. Systematic review and quality assessment of economic evaluation studies of injury prevention. Polinder S; Segui-Gomez M; Toet H; Belt E; Sethi D; Racioppi F; van Beeck EF Accid Anal Prev; 2012 Mar; 45():211-21. PubMed ID: 22269503 [TBL] [Abstract][Full Text] [Related]
36. Economic evaluations considering costs and outcomes of diabetic foot ulcer infections: A systematic review. Woods TJ; Tesfay F; Speck P; Kaambwa B PLoS One; 2020; 15(4):e0232395. PubMed ID: 32353082 [TBL] [Abstract][Full Text] [Related]
37. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation. Haasova M; Snowsill T; Jones-Hughes T; Crathorne L; Cooper C; Varley-Campbell J; Mujica-Mota R; Coelho H; Huxley N; Lowe J; Dudley J; Marks S; Hyde C; Bond M; Anderson R Health Technol Assess; 2016 Aug; 20(61):1-324. PubMed ID: 27557331 [TBL] [Abstract][Full Text] [Related]
38. The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation. Loveman E; Jones J; Hartwell D; Bird A; Harris P; Welch K; Clegg A Health Technol Assess; 2010 Mar; 14(19):1-204. PubMed ID: 20356561 [TBL] [Abstract][Full Text] [Related]